R&D News | pharmaphorum

News

BridgeBio raises $1.25bn, and other biotech financings

Our round-up of recent biotech financings is headed by a massive $1.25 billion round for genetic medicines specialist BridgeBio Pharma, with smaller rounds for Tr1X, Coman

News

DISCO dances out of the shadows with €20m for ‘surfaceome’

Germany has a new biotech, DISCO Pharmaceuticals, which has announced its presence with €20 million (around $22 million) in seed financing that will be used to advance its

News

AI could revolutionise pharma compound synthesis

Researchers at the University of Cambridge in the UK and Pfizer have developed an artificial intelligence (AI)-powered platform that could refine and accelerate the way ph

News

Update: Orion buys stake in LegoChem as biotech push goes on

Food group Orion Group has taken a 25% in South Korean biotech LegoChem Bioscience, becoming its largest shareholder, as part of a push into the biotech sector.

News

Bayer unit takes heart failure gene therapy into phase 2

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging da

News

Study finds hundreds of overlooked cancer drug targets

Researchers from the Wellcome Sanger Institute and partners have carried out a comprehensive analysis of cancer cells, identifying 370 ‘priority’ targets that could be use

BridgeBio raises $1.25bn, and other biotech financings

DISCO dances out of the shadows with €20m for ‘surfaceome’

AI could revolutionise pharma compound synthesis

Update: Orion buys stake in LegoChem as biotech push goes on

Bayer unit takes heart failure gene therapy into phase 2

Study finds hundreds of overlooked cancer drug targets

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks